ClinicalTrials.govpublic full text
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
non small cell lung cancer metastatic, ifct, albatros, nsclc, ros1-positive, monotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807893
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.